We recommend you to use Opko Health fundamental analysis to see if markets are presently mispricing the firm. In other words this interface allows you to confirm available drivers of Opko Health as well as the relationship between them. . We found twenty-seven available financial ratios for Opko Health which can be compared to its competitors. To make sure the equity is not overpriced, please check all Opko Health fundamentals including its Price to Sales, Debt to Equity, Z Score, as well as the relationship between Net Income and Earnings Per Share . Use Opko Health to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Opko Health to be traded at S1405.8 in 30 days
Opko Health Company Summary
Opko Health competes with Internet Gold, Bezeq Israel, and B Communications. OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was incorporated in 1991 and is headquartered in Miami, Florida. Opko Health operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 6030 people.
Opko Health Shares Owned by Institutions vs Price to Book
Opko Health is considered to be number one stock in shares owned by institutions category among related companies. It is considered to be number one stock in price to book category among related companies fabricating about 24.17 of Price to Book per Shares Owned by Institutions.
Opko Health Market Fundamentals
Opko Health Financial Distress Probability
Chance of Financial Distress
Opko Health has less than 25 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info